Financial Express - Feb. 2010

Troikaa drug to get US patent

Ahmedabad:

Troikaa Pharmaceuticals, a Gujarat-based fast growing healthcare company, is likely to get US patent for its novel drug delivery form of Diclofenac injections-Dyanapar AQ.

“Troikaa is shortly to get US patent for its Dyanapar AQ 1 ml injections, as proceedings at the USFDA have got over, we are just awaiting certificate and confirmation from them (USFDA),” Troikaa Pharmaceuticals MD Ketan Patel said. Diclofenac injections are used for management of painful inflammatory conditions, and, Dyanapar AQ, is the world’s first painkiller injection that can be administered on a patient’s shoulder. There is reportedly a huge market for these injections which the company is expected to tap.

“Proceeding for patent in Israel for this injection is also almost over and it would be received soon,” he said.